Clinical Trials Browser

Phase 1 × Inflammatory Breast Neoplasms × Carboplatin × Clear all

NCT05093387 2022-11-15

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Phase 1 Withdrawn

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00002616 2013-09-20

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Phase 1 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms